NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

ADMA

Adma Biologics Inc

Apr 17 • 04:00PM ET

21.31

Dollar change +0.08
Percentage change 0.38	%

Healthcare • Biotechnology • USA • NASD

Peers: CSL GRFS BAX BMY PFE JNJ MRK LLY COHR GILD

| Held by: IJR IWM VTI VXF XBI IJT IWO SPSM IBB XSMO

Scroll to Statements

Index	RUT	P/E	26.33	EPS (ttm)	0.81	Insider Own	3.50%	Shs Outstand	236.62M	Perf Week	14.08%
Market Cap	5.08B	Forward P/E	21.60	EPS next Y	0.99	Insider Trans	-1.26%	Shs Float	230.22M	Perf Month	3.40%
Income	197.67M	PEG	0.86	EPS next Q	0.16	Inst Own	86.26%	Short Float	5.63%	Perf Quarter	28.14%
Sales	426.45M	P/S	11.92	EPS this Y	45.61%	Inst Trans	-2.13%	Short Ratio	4.32	Perf Half Y	28.53%
Book/sh	1.48	P/B	14.45	EPS next Y	38.97%	ROA	47.77%	Short Interest	12.96M	Perf Year	245.94%
Cash/sh	0.43	P/C	49.29	EPS next 5Y	30.55%	ROE	81.65%	52W Range	5.97 - 23.64	Perf YTD	24.26%
Dividend Est.	-	P/FCF	46.03	EPS past 5Y	-	ROI	45.98%	52W High	-9.86%	Beta	0.56
Dividend TTM	-	Quick Ratio	2.90	Sales past 5Y	71.73%	Gross Margin	51.39%	52W Low	256.95%	ATR (14)	1.38
Dividend Ex-Date	-	Current Ratio	5.97	EPS Y/Y TTM	768.86%	Oper. Margin	32.59%	RSI (14)	60.15	Volatility	7.06% 6.77%
Employees	685	Debt/Eq	0.24	Sales Y/Y TTM	65.15%	Profit Margin	46.35%	Recom	1.50	Target Price	27.33
Option/Short	Yes / Yes	LT Debt/Eq	0.23	EPS Q/Q	682.59%	Payout	0.00%	Rel Volume	0.99	Prev Close	21.23
Sales Surprise	4.24%	EPS Surprise	-6.07%	Sales Q/Q	59.06%	Earnings	Mar 03 AMC	Avg Volume	3.00M	Price	21.31
SMA20	7.39%	SMA50	17.80%	SMA200	22.41%	Trades		Volume	2,964,495	Change	0.38%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-19-23	Resumed	Raymond James	Strong Buy	$5
Oct-13-22	Initiated	Mizuho	Buy	$5
Nov-11-21	Upgrade	Raymond James	Outperform → Strong Buy	$5
Nov-09-21	Initiated	Cantor Fitzgerald	Overweight	$4.50
Jun-04-19	Initiated	Jefferies	Buy	$8
Apr-15-19	Reiterated	H.C. Wainwright	Buy	$10 → $13
Feb-07-19	Resumed	H.C. Wainwright	Buy	$10
Dec-11-17	Reiterated	Maxim Group	Buy	$13 → $8
Nov-14-17	Upgrade	Raymond James	Mkt Perform → Outperform
Jan-23-17	Upgrade	Maxim Group	Hold → Buy	$13
Aug-01-16	Downgrade	Maxim Group	Buy → Hold
Jul-25-16	Reiterated	Maxim Group	Buy	$24 → $14
May-13-15	Reiterated	Maxim Group	Buy	$18 → $24
Dec-08-14	Initiated	Oppenheimer	Outperform	$20
Dec-01-14	Reiterated	Maxim Group	Buy	$16 → $18

Show Previous Ratings

Apr-17-25 05:50PM	Adma Biologics (ADMA) Beats Stock Market Upswing: What Investors Need to Know (Zacks)
09:17AM	GSK's Pentavalent Meningococcal Jab Recommended for Use by ACIP (Zacks)
09:09AM	ADMA Biologics (ADMA): Among Louis Navellier's New Stock Picks (Insider Monkey)
Apr-16-25 09:48AM	MURA Soars as it Explores Strategic Options Post Cancer Study Failures (Zacks)
09:30AM	Adma Biologics (ADMA) Is Considered a Good Investment by Brokers: Is That True? (Zacks)
08:52AM	Loading…
08:52AM	DTIL Gets FDA's Fast Track Tag for Hepatitis B Gene Therapy, Stock Up (Zacks)
06:45AM	Why ADMA Biologics, Inc. (ADMA) Skyrocketed On Tuesday? (Insider Monkey)
Apr-15-25 12:27PM	VERV Stock Soars on Superior Efficacy in Phase I Cholesterol Study (Zacks) +5.93%
10:42AM	Fate Therapeutics' Lupus Candidate FT819 Gets FDA RMAT Tag (Zacks)
09:40AM	Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year? (Zacks)
09:35AM	Adma Biologics (ADMA) Just Overtook the 20-Day Moving Average (Zacks)
09:18AM	Ironwood Shares Tank on Regulatory Update for Apraglutide (Zacks)
08:59AM	Adma Biologics (ADMA) Moves 7.8% Higher: Will This Strength Last? (Zacks)
08:50AM	Adma Biologics (ADMA) is on the Move, Here's Why the Trend Could be Sustainable (Zacks)
12:41AM	Why ADMA Biologics Inc. (ADMA) Skyrocketed On Monday? (Insider Monkey)
09:51AM	Loading…
Apr-14-25 09:51AM	Roche Gets Nod for Expanded Use of Columvi in Lymphoma in Europe (Zacks) +7.78%
Apr-11-25 01:17PM	NVS Plans to Invest $23B in US Manufacturing Sites Amid Tariff Threat (Zacks)
11:57AM	KROS Initiates Exploring Strategic Alternatives, Stock Gains 18.5% (Zacks)
11:49AM	Arcturus Gets FDA's Fast Track Tag for Influenza Vaccine Candidate (Zacks)
Apr-10-25 10:53AM	PHIO Stock Soars as Safety Panel Clears Skin Cancer Drug for Next Dose (Zacks)
09:58AM	ANIX Gets New Patent for Breast Cancer Vaccine Technology, Stock Up (Zacks)
Apr-09-25 10:01AM	RXRX Doses First Patient in Early-Stage B-Cell Lymphomas Study (Zacks) +8.57%
Apr-08-25 05:10PM	Nurix Therapeutics, Inc. (NRIX) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
03:42PM	Rhythm Pharmaceuticals Stock Earns RS Rating Upgrade (Investor's Business Daily)
11:29AM	PCRX Stock Soars on Exparel Patent Settlement With Generic Players (Zacks)
11:21AM	RYTM Stock Rises 17% on Meeting Goals in Hypothalamic Obesity Study (Zacks)
09:56AM	Viatris to Pay $335 Million for Settlement of Opioid-Related Claims (Zacks)
Apr-07-25 01:22PM	5 Biotech Stocks Worth Adding Amid Global Uncertainty in 2025 (Zacks)
12:17PM	EWTX Stock Down 48% in a Week Despite Upbeat Cardiomyopathy Study Data (Zacks)
09:55AM	Does Adma Biologics (ADMA) Have the Potential to Rally 51.75% as Wall Street Analysts Expect? (Zacks)
07:00AM	Loading…
07:00AM	ADMA Biologics Statement on Tariffs (GlobeNewswire)
Apr-03-25 01:09PM	Ensign Group Invests in Growth With New Facility Acquisitions (Zacks)
Mar-31-25 08:51PM	Lightning Round: I don't trust Wendy's, says Jim Cramer (CNBC TV)
09:30AM	Wall Street Analysts See Adma Biologics (ADMA) as a Buy: Should You Invest? (Zacks)
Mar-28-25 05:45PM	Adma Biologics (ADMA) Stock Moves -0.15%: What You Should Know (Zacks)
11:06AM	Centene & HMHB Hawaii Expand Partnership for Maternal Care (Zacks)
Mar-27-25 04:48PM	How IBD Stock Of The Day ADMA Biologics Shrugged Off Accounting Debacle For A Bullish Comeback (Investor's Business Daily)
Mar-26-25 09:55AM	Adma Biologics (ADMA) Just Flashed Golden Cross Signal: Do You Buy? (Zacks)
Mar-21-25 04:43PM	Here is What to Know Beyond Why ADMA Biologics Inc (ADMA) is a Trending Stock (Zacks)
03:04PM	ADMA Biologics: Premium Valuation Justified By Strong Fundamentals And Future Potential (SeekingAlpha)
09:55AM	Wall Street Analysts Predict a 39.08% Upside in Adma Biologics (ADMA): Here's What You Should Know (Zacks)
Mar-20-25 12:29PM	ADMA Stock Builds A Base As Profits Continue To Soar (Investor's Business Daily)
09:28AM	Adma Biologics (ADMA) Surges 10.2%: Is This an Indication of Further Gains? (Zacks)
08:50AM	Recent Price Trend in Adma Biologics (ADMA) is Your Friend, Here's Why (Zacks)
Mar-19-25 09:02PM	Why ADMA Biologics Inc. (ADMA) Went Up On Wednesday? (InsiderMonkey) +10.16%
Mar-17-25 05:50PM	Why Adma Biologics (ADMA) Outpaced the Stock Market Today (Zacks)
Mar-13-25 09:30AM	Should You Invest in Adma Biologics (ADMA) Based on Bullish Wall Street Views? (Zacks)
Mar-12-25 09:30AM	Adma Biologics (ADMA) Recently Broke Out Above the 50-Day Moving Average (Zacks) +6.63%
Mar-07-25 07:00AM	How This Top Small-Cap Growth Fund Wins Big (Investor's Business Daily)
Mar-05-25 09:55AM	How Much Upside is Left in Adma Biologics (ADMA)? Wall Street Analysts Think 52.85% (Zacks)
Mar-04-25 11:54AM	Q4 2024 ADMA Biologics Inc Earnings Call (Thomson Reuters StreetEvents) +7.45%
02:03AM	ADMA Biologics Inc (ADMA) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... (GuruFocus.com)
Mar-03-25 04:29PM	Adma Biologics: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	ADMA Biologics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update (GlobeNewswire)
Feb-28-25 07:05AM	ADMA Biologics Inc (ADMA) Q4 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com) +6.15%
07:00AM	ADMA Biologics to Participate in the Raymond James Institutional Investor Conference (GlobeNewswire)
Feb-25-25 09:30AM	Wall Street Analysts Look Bullish on Adma Biologics (ADMA): Should You Buy? (Zacks)
07:00AM	ADMA Biologics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025 (GlobeNewswire)
Feb-21-25 05:45PM	Adma Biologics (ADMA) Stock Moves -1.49%: What You Should Know (Zacks)
Feb-19-25 05:50PM	Adma Biologics (ADMA) Stock Slides as Market Rises: Facts to Know Before You Trade (Zacks)
Feb-12-25 05:45PM	Adma Biologics (ADMA) Stock Moves -0.25%: What You Should Know (Zacks)
Feb-06-25 05:45PM	Adma Biologics (ADMA) Advances But Underperforms Market: Key Facts (Zacks)
Feb-03-25 05:50PM	Adma Biologics (ADMA) Ascends While Market Falls: Some Facts to Note (Zacks)
Jan-30-25 03:18PM	Jim Cramer on ADMA Biologics, Inc. (ADMA): I Would Wait For It To Come Down Before I Would Pull The Trigger (Insider Monkey)
Jan-28-25 05:50PM	Adma Biologics (ADMA) Stock Declines While Market Improves: Some Information for Investors (Zacks)
Jan-22-25 05:50PM	Adma Biologics (ADMA) Rises Higher Than Market: Key Facts (Zacks)
Jan-18-25 02:01PM	ADMA Biologics Inc. (ADMA): Why Should You Buy This Growth Stock For The Next 5 Years? (Insider Monkey)
Jan-14-25 05:50PM	Adma Biologics (ADMA) Stock Sinks As Market Gains: Here's Why (Zacks)
Jan-13-25 07:00AM	ADMA Biologics Announces Preliminary Full Year 2024 Revenue and Provides Business Update (GlobeNewswire) -11.15%
Jan-11-25 10:00AM	The Top Stock Funds of 2024 (The Wall Street Journal)
Jan-09-25 04:53PM	Is ADMA Biologics, Inc. (ADMA) the Best Growth Stock to Buy Now Under $25? (Insider Monkey)
Jan-08-25 05:50PM	Adma Biologics (ADMA) Surpasses Market Returns: Some Facts Worth Knowing (Zacks)
02:54PM	SpringWorks Therapeutics Stock Gets A RS Rating Lift (Investor's Business Daily)
09:30AM	Is It Worth Investing in Adma Biologics (ADMA) Based on Wall Street's Bullish Views? (Zacks)
Jan-07-25 07:00AM	ADMA Biologics to Participate in the J.P. Morgan Healthcare Conference on January 13, 2025 (GlobeNewswire)
Jan-01-25 12:39PM	Why Is ADMA Biologics, Inc. (ADMA) Among the Best Multibagger Stocks to Buy Right Now? (Insider Monkey)
Dec-27-24 02:09PM	Arcellx Stock Earns 82 Relative Strength Rating (Investor's Business Daily)
Dec-20-24 07:00AM	ADMA Biologics Announces Partial Paydown of Senior Term Loan Credit Facility (GlobeNewswire)
Dec-11-24 03:06PM	NewAmsterdam Pharma Stock Hits 90-Plus RS Rating (Investor's Business Daily)
Dec-04-24 09:55AM	Can Adma Biologics (ADMA) Climb 25.5% to Reach the Level Wall Street Analysts Expect? (Zacks)
Dec-02-24 02:16PM	Is Adma Biologics (ADMA) a Buy as Wall Street Analysts Look Optimistic? (Zacks)
Nov-27-24 09:40AM	Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year? (Zacks)
Nov-26-24 09:51AM	Biotech Leader ADMA Hits New Buy Point After Recovering From Surprise Plunge (Investor's Business Daily)
Nov-18-24 09:55AM	Wall Street Analysts See a 31.3% Upside in Adma Biologics (ADMA): Can the Stock Really Move This High? (Zacks)
Nov-15-24 09:30AM	Brokers Suggest Investing in Adma Biologics (ADMA): Read This Before Placing a Bet (Zacks) -5.74%
Nov-12-24 09:15AM	ADMA Biologics Inc (ADMA) Hits Fresh High: Is There Still Room to Run? (Zacks)
Nov-11-24 02:06PM	Vericel Stock Sees RS Rating Shoot Higher (Investor's Business Daily)
Nov-08-24 12:19PM	Q3 2024 ADMA Biologics Inc Earnings Call (Thomson Reuters StreetEvents) +14.71%
06:37AM	ADMA INVESTOR NEWS: ADMA Biologics Investors with Losses May have been Affected by Fraud; Contact BFA Law (Nasdaq:ADMA) (GlobeNewswire)
02:28AM	ADMA Biologics Inc (ADMA) Q3 2024 Earnings Call Highlights: Record Revenue and Net Income Surge (GuruFocus.com)
Nov-07-24 07:20PM	Adma Biologics (ADMA) Q3 Earnings and Revenues Beat Estimates (Zacks)
06:17PM	Adma Biologics: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	ADMA Biologics Announces Third Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
Nov-06-24 07:08AM	ADMA Biologics Inc (ADMA) Q3 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Nov-04-24 02:34PM	Adma Biologics (ADMA) Soars 18.8%: Is Further Upside Left in the Stock? (Zacks)
Nov-01-24 04:08PM	ADMA Biologics, A Top 1% Stock, Skyrockets After Settling Its Accounting Debacle (Investor's Business Daily) +18.76%
Oct-30-24 09:30AM	Wall Street Bulls Look Optimistic About Adma Biologics (ADMA): Should You Buy? (Zacks)
Oct-29-24 05:50PM	Adma Biologics (ADMA) Exceeds Market Returns: Some Facts to Consider (Zacks)
04:10PM	ADMA Biologics to Report Third Quarter 2024 Financial Results on November 7, 2024 (GlobeNewswire)
Oct-21-24 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating ADMA Biologics, Napco, and L&W and Encourages Investors to Contact the Firm (GlobeNewswire)

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Grossman Adam S	President and CEO	Apr 15 '25	Option Exercise	5.40	15,000	81,000	2,076,850	Apr 16 09:00 PM
Grossman Adam S	President and CEO	Apr 15 '25	Sale	21.46	21,000	450,660	2,055,850	Apr 16 09:00 PM
Grossman Adam S	President and CEO	Mar 19 '25	Option Exercise	5.40	15,000	81,000	2,082,850	Mar 21 09:00 PM
Grossman Adam S	President and CEO	Mar 19 '25	Sale	18.92	21,000	397,320	2,061,850	Mar 21 09:00 PM
Grossman Adam S	Director and Officer	Mar 19 '25	Proposed Sale	18.71	84,000	1,571,640		Mar 19 09:40 PM
Kestenberg-Messina Kaitlin M.	COO and SVP, Compliance	Jan 30 '25	Option Exercise	10.80	5,000	54,000	449,587	Feb 03 09:00 PM
ELMS STEVE	Director	Nov 27 '24	Option Exercise	10.80	9,000	97,200	2,124,671	Dec 02 09:02 PM
Tade Brad L.	CFO and Treasurer	Nov 22 '24	Sale	21.15	15,000	317,250	199,433	Nov 22 09:05 PM
Grossman Adam S	President and CEO	Nov 22 '24	Sale	21.10	48,967	1,033,204	1,989,007	Nov 22 09:05 PM
Grossman Adam S	Director and Officer	Nov 22 '24	Proposed Sale	21.30	48,967	1,042,997		Nov 22 09:00 PM
Tade Brad L.	Officer	Nov 22 '24	Proposed Sale	21.30	15,000	319,500		Nov 22 09:00 PM
Guiheen Lawrence P.	Director	Sep 09 '24	Option Exercise	10.80	9,000	97,200	162,941	Sep 11 09:00 PM
Guiheen Lawrence P.	Director	Sep 09 '24	Sale	18.47	9,000	166,189	153,941	Sep 11 09:00 PM
Guiheen Lawrence P.	Director	Sep 09 '24	Proposed Sale	16.26	9,000	146,340		Sep 09 09:00 PM
Kestenberg-Messina Kaitlin M.	COO and SVP, Compliance	Aug 30 '24	Option Exercise	3.87	24,150	93,526	473,238	Aug 30 09:05 PM
Kestenberg-Messina Kaitlin M.	COO and SVP, Compliance	Aug 30 '24	Sale	16.90	24,150	408,050	449,088	Aug 30 09:05 PM
Grossman Jerrold B	Director	Aug 29 '24	Option Exercise	4.28	136,861	585,871	604,166	Aug 30 09:02 PM
Grossman Jerrold B	Director	Aug 29 '24	Sale	17.27	136,861	2,363,932	467,305	Aug 30 09:02 PM
Kestenberg-Messina Kaitlin M.	Officer	Aug 30 '24	Proposed Sale	17.22	24,150	415,863		Aug 30 09:00 PM
Grossman Jerrold B	Director	Aug 29 '24	Proposed Sale	17.24	136,861	2,359,484		Aug 29 09:26 PM
Grossman Adam S	President and CEO	Aug 26 '24	Option Exercise	6.84	236,889	1,619,466	2,296,615	Aug 27 09:22 PM
Grossman Adam S	President and CEO	Aug 27 '24	Option Exercise	3.30	389,356	1,283,725	2,449,082	Aug 27 09:22 PM
Grossman Adam S	President and CEO	Aug 27 '24	Sale	17.29	389,356	6,732,900	2,059,726	Aug 27 09:22 PM
Grossman Adam S	President and CEO	Aug 26 '24	Sale	17.69	236,889	4,191,088	2,059,726	Aug 27 09:22 PM
KWON YOUNG	Director	Aug 23 '24	Sale	18.26	60,000	1,095,600	241,441	Aug 27 09:00 PM
Grossman Adam S	Officer	Aug 26 '24	Proposed Sale	18.20	626,245	11,397,659		Aug 26 09:28 PM
Grossman Adam S	President,CEO, and Interim CFO	Jun 14 '24	Sale	10.72	100,000	1,071,980	2,081,475	Jun 14 09:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ADMA

Adma Biologics Inc

Upgrade your FINVIZ experience